JP2009528344A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009528344A5 JP2009528344A5 JP2008557232A JP2008557232A JP2009528344A5 JP 2009528344 A5 JP2009528344 A5 JP 2009528344A5 JP 2008557232 A JP2008557232 A JP 2008557232A JP 2008557232 A JP2008557232 A JP 2008557232A JP 2009528344 A5 JP2009528344 A5 JP 2009528344A5
- Authority
- JP
- Japan
- Prior art keywords
- salt
- disease
- salt according
- dementia
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000003839 salts Chemical class 0.000 claims 22
- 238000000634 powder X-ray diffraction Methods 0.000 claims 6
- 208000010877 cognitive disease Diseases 0.000 claims 5
- BLTVBQXJFVRPFK-UHFFFAOYSA-N AZD1080 Chemical compound OC=1NC2=CC=C(C#N)C=C2C=1C(N=C1)=CC=C1CN1CCOCC1 BLTVBQXJFVRPFK-UHFFFAOYSA-N 0.000 claims 4
- 206010012289 Dementia Diseases 0.000 claims 4
- 201000011240 Frontotemporal dementia Diseases 0.000 claims 4
- 208000024827 Alzheimer disease Diseases 0.000 claims 3
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 claims 3
- 208000028698 Cognitive impairment Diseases 0.000 claims 3
- 208000024714 major depressive disease Diseases 0.000 claims 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims 3
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 claims 2
- 208000020925 Bipolar disease Diseases 0.000 claims 2
- 208000026072 Motor neurone disease Diseases 0.000 claims 2
- 229910019142 PO4 Inorganic materials 0.000 claims 2
- 208000018737 Parkinson disease Diseases 0.000 claims 2
- 208000030886 Traumatic Brain injury Diseases 0.000 claims 2
- 208000015802 attention deficit-hyperactivity disease Diseases 0.000 claims 2
- -1 edicylate Chemical compound 0.000 claims 2
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 claims 2
- 208000035231 inattentive type attention deficit hyperactivity disease Diseases 0.000 claims 2
- 208000027061 mild cognitive impairment Diseases 0.000 claims 2
- 208000005264 motor neuron disease Diseases 0.000 claims 2
- 239000010452 phosphate Substances 0.000 claims 2
- 201000002212 progressive supranuclear palsy Diseases 0.000 claims 2
- 201000000980 schizophrenia Diseases 0.000 claims 2
- 230000009529 traumatic brain injury Effects 0.000 claims 2
- UWVRIYXOBCKXBK-WLHGVMLRSA-N (E)-but-2-enedioic acid 2-hydroxy-3-[5-(morpholin-4-ylmethyl)pyridin-2-yl]-1H-indole-5-carbonitrile Chemical compound OC(=O)\C=C\C(O)=O.Oc1[nH]c2ccc(C#N)cc2c1-c(nc1)ccc1CN1CCOCC1 UWVRIYXOBCKXBK-WLHGVMLRSA-N 0.000 claims 1
- DTYCKRIVOIWJCW-UHFFFAOYSA-N 2-hydroxy-3-[5-(morpholin-4-ylmethyl)pyridin-2-yl]-1H-indole-5-carbonitrile methanesulfonic acid Chemical compound CS(O)(=O)=O.Oc1[nH]c2ccc(cc2c1-c1ccc(CN2CCOCC2)cn1)C#N DTYCKRIVOIWJCW-UHFFFAOYSA-N 0.000 claims 1
- 208000017194 Affective disease Diseases 0.000 claims 1
- 208000020406 Creutzfeldt Jacob disease Diseases 0.000 claims 1
- 208000003407 Creutzfeldt-Jakob Syndrome Diseases 0.000 claims 1
- 208000010859 Creutzfeldt-Jakob disease Diseases 0.000 claims 1
- 102100038076 DNA dC->dU-editing enzyme APOBEC-3G Human genes 0.000 claims 1
- 201000010374 Down Syndrome Diseases 0.000 claims 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims 1
- 101000742736 Homo sapiens DNA dC->dU-editing enzyme APOBEC-3G Proteins 0.000 claims 1
- 208000023105 Huntington disease Diseases 0.000 claims 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims 1
- 208000019022 Mood disease Diseases 0.000 claims 1
- 208000014060 Niemann-Pick disease Diseases 0.000 claims 1
- 206010034010 Parkinsonism Diseases 0.000 claims 1
- 208000000609 Pick Disease of the Brain Diseases 0.000 claims 1
- 208000024777 Prion disease Diseases 0.000 claims 1
- 208000028017 Psychotic disease Diseases 0.000 claims 1
- 208000034189 Sclerosis Diseases 0.000 claims 1
- 201000004810 Vascular dementia Diseases 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 230000032683 aging Effects 0.000 claims 1
- 210000004227 basal ganglia Anatomy 0.000 claims 1
- 208000028683 bipolar I disease Diseases 0.000 claims 1
- 208000025307 bipolar depression Diseases 0.000 claims 1
- 230000007278 cognition impairment Effects 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 230000001054 cortical effect Effects 0.000 claims 1
- 230000007850 degeneration Effects 0.000 claims 1
- 208000017004 dementia pugilistica Diseases 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 210000004558 lewy body Anatomy 0.000 claims 1
- 238000012423 maintenance Methods 0.000 claims 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims 1
- 206010027175 memory impairment Diseases 0.000 claims 1
- 230000036651 mood Effects 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 230000001568 sexual effect Effects 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77734806P | 2006-02-28 | 2006-02-28 | |
| PCT/SE2007/000089 WO2007100282A1 (en) | 2006-02-28 | 2007-01-31 | New salts of an indole derivative and their use in medicine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009528344A JP2009528344A (ja) | 2009-08-06 |
| JP2009528344A5 true JP2009528344A5 (enExample) | 2011-02-10 |
Family
ID=38459317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008557232A Pending JP2009528344A (ja) | 2006-02-28 | 2007-01-31 | インドール誘導体の新規な塩及び医薬におけるその使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20120115865A1 (enExample) |
| EP (1) | EP1991539A4 (enExample) |
| JP (1) | JP2009528344A (enExample) |
| CN (1) | CN101389623A (enExample) |
| WO (1) | WO2007100282A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101851234A (zh) * | 2009-04-03 | 2010-10-06 | 上海日馨生物科技有限公司 | 吡咯喹啉醌锂盐衍生物及其制备方法 |
| CN101758337B (zh) | 2009-12-03 | 2012-02-15 | 湖南阿斯达生化科技有限公司 | 一种助焊剂用非卤素活性剂 |
| WO2020163812A1 (en) | 2019-02-08 | 2020-08-13 | Frequency Therapeutics, Inc. | Valproic acid compounds and wnt agonists for treating ear disorders |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0101765D0 (sv) * | 2001-05-18 | 2001-05-18 | Astrazeneca Ab | Novel compounds |
| GB0124941D0 (en) * | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
| CN100369898C (zh) * | 2002-02-12 | 2008-02-20 | 史密丝克莱恩比彻姆公司 | 用作p38抑制剂的烟酰胺衍生物 |
| SE0200979D0 (sv) * | 2002-03-28 | 2002-03-28 | Astrazeneca Ab | New compounds |
| SE0302546D0 (sv) * | 2003-09-24 | 2003-09-24 | Astrazeneca Ab | New compounds |
| ATE481397T1 (de) * | 2002-04-24 | 2010-10-15 | Merck Sharp & Dohme | Modulatoren des östrogenrezeptors |
| WO2003101978A1 (en) * | 2002-05-29 | 2003-12-11 | Eli Lilly And Company | Phenyl-thiophene type vitamin d receptor modulators |
| GB0219153D0 (en) * | 2002-08-16 | 2002-09-25 | Pfizer Ltd | Substituted glycine derivatives for use as medicaments |
-
2007
- 2007-01-31 CN CNA2007800069734A patent/CN101389623A/zh active Pending
- 2007-01-31 US US12/280,270 patent/US20120115865A1/en not_active Abandoned
- 2007-01-31 WO PCT/SE2007/000089 patent/WO2007100282A1/en not_active Ceased
- 2007-01-31 JP JP2008557232A patent/JP2009528344A/ja active Pending
- 2007-01-31 EP EP07709305A patent/EP1991539A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010535200A5 (enExample) | ||
| JP2012532125A5 (enExample) | ||
| MX2010003346A (es) | Piperazino-dihidrotienopirimidinas sustituidas en heterociclo. | |
| JP2008514627A5 (enExample) | ||
| EA201071298A1 (ru) | Соединение 3-аминокарбазола, фармацевтическая композиция, его содержащая, и способ их получения | |
| CO6361928A2 (es) | Modulares de aril metil benzoquinazolinona alostericos positivos del receptor m1 | |
| JP2021527031A5 (enExample) | ||
| JP2017531020A5 (enExample) | ||
| JP2015511958A5 (enExample) | ||
| UA99309C2 (ru) | Замещенные пиперидинодигидротиенопиримидины | |
| RU2009135616A (ru) | НОВЫЕ АМИДАЗО[4,5-b]ПИРИДИН-7-КАРБОКСАМИДЫ 704 | |
| JP2004534816A5 (enExample) | ||
| JP2019513745A5 (enExample) | ||
| RU2011140238A (ru) | Имидазол-замещенные пиримидины, полезные в лечении заболеваний, ассоциированных с киназой-3 гликогенсинтазы, таких как болезнь альцгеймера | |
| MX2011007774A (es) | Derivados de isoxazol-isoxazol e isoxazol-isotiazol. | |
| JP2019534327A5 (enExample) | ||
| JP2009525324A5 (enExample) | ||
| PE20120005A1 (es) | Derivados de (2s,3r)-n-2-((3-piridinil)metil)-1-azabiciclo[2.2.2]oct-3-il)-3,5-difluorobenzamida | |
| FI3856341T3 (fi) | (s)-1-(4-fluorifenyyli)-1-(2-(4-(6-(1-metyyli-1h-pyratsol-4-yyli)pyrrolo[2,1-f][1,2,4]triatsin-4-yyli)piperatsinyyli)pyrimidin-5-yyli)etaani-1-amiinin kidemuotoja ja valmistusmenetelmiä | |
| MX2013011290A (es) | Derivados de pirrol como moduladores de los receptores de acetilcolina nicotinicos para su uso en el tratamiento de enfermedades neurodegenerativas como el alzheimer y la enfermedad de parkinson. | |
| JP2021534227A5 (enExample) | ||
| JP2017502961A5 (enExample) | ||
| JP2011516588A5 (enExample) | ||
| JP2006519868A5 (enExample) | ||
| JP2005508381A5 (enExample) |